Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001736730-25-000094
Filing Date
2025-11-06
Accepted
2025-11-06 16:19:26
Documents
81
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q camp-20250930.htm   iXBRL 10-Q 1022211
2 EX-31.1 camp-20250930x10qexx311.htm EX-31.1 10834
3 EX-31.2 camp-20250930x10qexx312.htm EX-31.2 10950
4 EX-32.1 camp-20250930x10qexx321.htm EX-32.1 5550
5 EX-32.2 camp-20250930x10qexx322.htm EX-32.2 5555
11 camp-20250930_g1.jpg GRAPHIC 9296
  Complete submission text file 0001736730-25-000094.txt   6465781

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT camp-20250930.xsd EX-101.SCH 55705
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT camp-20250930_cal.xml EX-101.CAL 70162
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT camp-20250930_def.xml EX-101.DEF 230997
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT camp-20250930_lab.xml EX-101.LAB 657776
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT camp-20250930_pre.xml EX-101.PRE 479077
84 EXTRACTED XBRL INSTANCE DOCUMENT camp-20250930_htm.xml XML 774180
Mailing Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 WEST, 3RD FLOOR CAMBRIDGE MA 02139 617-651-8867
Camp4 Therapeutics Corp (Filer) CIK: 0001736730 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42365 | Film No.: 251458602
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)